BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30553402)

  • 1. Combined administration of docosahexaenoic acid and thyroid hormone synergistically enhances rat liver levels of resolvins RvD1 and RvD2.
    Videla LA; Vargas R; Valenzuela R; Muñoz P; Corbari A; Hernandez-Rodas MC
    Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():42-46. PubMed ID: 30553402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of high-fat diet-induced liver proinflammatory state by eicosapentaenoic acid plus hydroxytyrosol supplementation: involvement of resolvins RvE1/2 and RvD1/2.
    Echeverría F; Valenzuela R; Espinosa A; Bustamante A; Álvarez D; Gonzalez-Mañan D; Ortiz M; Soto-Alarcon SA; Videla LA
    J Nutr Biochem; 2019 Jan; 63():35-43. PubMed ID: 30321750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.
    Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR
    J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
    Serhan CN; Gotlinger K; Hong S; Arita M
    Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid-thyroid hormone combined protocol as a novel approach to metabolic stress disorders: Relation to mitochondrial adaptation via liver PGC-1α and sirtuin1 activation.
    Vargas R; Riquelme B; Fernández J; Álvarez D; Pérez IF; Cornejo P; Fernández V; Videla LA
    Biofactors; 2019 Mar; 45(2):271-278. PubMed ID: 30578580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined docosahexaenoic acid-thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions.
    Vargas R; Riquelme B; Fernández J; Videla LA
    Food Funct; 2017 Nov; 8(11):3980-3988. PubMed ID: 28990606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
    Serhan CN; Arita M; Hong S; Gotlinger K
    Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of rat liver PPARα-FGF21 signaling by a docosahexaenoic acid and thyroid hormone combined protocol.
    Videla LA; Fernández V; Vargas R; Cornejo P; Tapia G; Varela N; Valenzuela R; Arenas A; Fernández J; Hernández-Rodas MC; Riquelme B
    Biofactors; 2016 Nov; 42(6):638-646. PubMed ID: 27248050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions.
    Tian H; Lu Y; Sherwood AM; Hongqian D; Hong S
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3613-20. PubMed ID: 19443724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk mechanisms in hepatoprotection: Thyroid hormone-docosahexaenoic acid (DHA) and DHA-extra virgin olive oil combined protocols.
    Valenzuela R; Videla LA
    Pharmacol Res; 2018 Jun; 132():168-175. PubMed ID: 29253525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
    Mas E; Croft KD; Zahra P; Barden A; Mori TA
    Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
    See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
    Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.
    Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J
    Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619.
    Jannaway M; Torrens C; Warner JA; Sampson AP
    Br J Pharmacol; 2018 Apr; 175(7):1100-1108. PubMed ID: 29352769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats.
    Zhang T; Shu HH; Chang L; Ye F; Xu KQ; Huang WQ
    Int Immunopharmacol; 2015 Sep; 28(1):322-7. PubMed ID: 26118631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
    Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
    Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of resolvins in the resolution of inflammation and pain.
    Ji RR; Xu ZZ; Strichartz G; Serhan CN
    Trends Neurosci; 2011 Nov; 34(11):599-609. PubMed ID: 21963090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
    Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
    J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
    Rey C; Nadjar A; Buaud B; Vaysse C; Aubert A; Pallet V; Layé S; Joffre C
    Brain Behav Immun; 2016 Jul; 55():249-259. PubMed ID: 26718448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats.
    Atkinson TG; Barker HJ; Meckling-Gill KA
    Lipids; 1997 Mar; 32(3):293-302. PubMed ID: 9076666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.